Home » Business » Manufacturing
Human Genome deal?
Source: Agencies |
July 16, 2012, Monday
|
Print Edition
Print Edition
GLAXOSMITHKLINE is holding talks to buy Human Genome Sciences for some US$2.6 billion, after pursuing the US biotech firm for three months, sources said yesterday.
Human Genome, which rejected a US$13-a-share offer in April from GlaxoSmithKline, its long-time partner, has come under pressure from investors to try and strike a deal with the British drugmaker in the absence of any alternative bids. The US company - an early pioneer of gene-based drug discovery - has set itself a deadline that ends today for finding higher bids.
Human Genome, which rejected a US$13-a-share offer in April from GlaxoSmithKline, its long-time partner, has come under pressure from investors to try and strike a deal with the British drugmaker in the absence of any alternative bids. The US company - an early pioneer of gene-based drug discovery - has set itself a deadline that ends today for finding higher bids.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
